Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LiveSpo COLON
- Development stage
- Unknown
- Lead developer
- LiveSpo Pharma
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
LiveSpo COLON is a liquid spore-form probiotic supplement developed by LiveSpo Pharma for the supportive treatment of ulcerative colitis (UC) and irritable bowel syndrome (IBS). Each 5mL vial contains 3 billion CFU of a multi-strain blend including *Bacillus subtilis*, *Bacillus clausii*, and *Bacillus coagulans* suspended in purified water. The product utilizes proprietary Spore Liquid (SPL) Technology, which ensures the probiotics remain stable at room temperature and survive the gastric acid barrier to reach the intestines. Once in the gut, the spores germinate into active bacteria that help balance the intestinal microbiota, synthesize natural antimicrobial substances to eliminate harmful pathogens, and reduce inflammation. Notably, the *Bacillus subtilis* strain is capable of forming a protective biofilm over colonic ulcers, facilitating the healing process and managing symptoms such as abdominal pain, diarrhea, and constipation.
- Brand names
- LiveSpo COLON
Beyond the preview
Go deeper on LiveSpo COLON.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LiveSpo COLON.